IDH Inhibitors Market Expansion Anchored by IDH1 and IDH2 Inhibitor...

added blog Health

2025-10-24 11:46:19

IDH Inhibitors Market Expansion Anchored by IDH1 and IDH2 Inhibitor Segments

Isocitrate dehydrogenase (IDH) inhibitors market target mutated IDH 1 and IDH 2 enzymes, which contribute to abnormal metabolism and proliferation in certain cancers, including acute myeloid leukemia, cholangiocarcinoma, and glioma. The market is expected to grow rapidly as more IDH‑mutated cancers are identified and treated with targeted therapies. Download Sample PDF: Market...

0 Comments 0 Shares 285 Views 0 Reviews